متابعة
Rajat Desikan`
Rajat Desikan`
Director, GSK, UK
بريد إلكتروني تم التحقق منه على gsk.com - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
P Padmanabhan, R Desikan, NM Dixit
PLoS computational biology 16 (12), e1008461, 2020
1252020
Modeling how antibody responses may determine the efficacy of COVID-19 vaccines
P Padmanabhan, R Desikan, NM Dixit
Nature Computational Science 2 (2), 123-131, 2022
42*2022
Preferential presentation of high-affinity immune complexes in germinal centers can explain how passive immunization improves the humoral response
AK Garg, R Desikan, NM Dixit
Cell Reports 29 (12), 3946-3957. e5, 2019
372019
Capturing the Membrane-Triggered Conformational Transition of an α-Helical Pore-Forming Toxin
VVH Giri Rao, R Desikan, KG Ayappa, S Gosavi
The Journal of Physical Chemistry B 120 (47), 12064-12078, 2016
292016
Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost
AK Garg, S Mittal, P Padmanabhan, R Desikan, NM Dixit
Frontiers in immunology 12, 776933, 2021
272021
Assessing the structure and stability of transmembrane oligomeric intermediates of an α-helical toxin
R Desikan, PK Maiti, KG Ayappa
Langmuir 33 (42), 11496-11510, 2017
242017
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
Rajat Desikan, Rubesh Raja, Narendra M. Dixit
PLoS Computational Biology 16 (8), 1-30, 2020
22*2020
Comparison of coarse-grained (MARTINI) and atomistic molecular dynamics simulations of α and β toxin nanopores in lipid membranes
R Desikan, SM Patra, K Sarthak, PK Maiti, KG Ayappa
Journal of Chemical Sciences 129 (7), 1017-1030, 2017
192017
Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
M Giorgi, R Desikan, PH van Der Graaf, AM Kierzek
CPT: pharmacometrics & systems pharmacology 10 (10), 1130-1133, 2021
182021
Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics
R Desikan, P Padmanabhan, AM Kierzek, PH van der Graaf
International Journal of Antimicrobial Agents, 106606, 2022
172022
The solvent-exposed c-terminus of the cytolysin A pore-forming toxin directs pore formation and channel function in membranes
P Sathyanarayana, R Desikan, KG Ayappa, SS Visweswariah
Biochemistry 55 (42), 5952-5961, 2016
172016
Opening of smaller toxin pores by lipid micelle formation
R Desikan, P Padmanabhan, KG Ayappa
Proceedings of the National Academy of Sciences 117 (10), 5107-5108, 2020
122020
Assessing the extent of the structural and dynamic modulation of membrane lipids due to pore forming toxins: insights from molecular dynamics simulations
V Varadarajan, R Desikan, KG Ayappa
Soft Matter 16 (20), 4840-4857, 2020
122020
Using multiscale molecular dynamics simulations to obtain insights into pore forming toxin mechanisms
R Desikan, A Behera, PK Maiti, GK Ayappa
Methods in Enzymology (Chapter Sixteen) 649, 461-502, 2021
92021
Evaluating coarse-grained MARTINI force-fields for capturing the ripple phase of lipid membranes
P Sharma, R Desikan, KG Ayappa
The Journal of Physical Chemistry B 125 (24), 6359-6732, 2021
82021
Physical ‘strength’of the multi‐protein chain connecting immune cells: Does the weakest link limit antibody affinity maturation? The weakest link in the multi‐protein chain …
R Desikan, R Antia, NM Dixit
BioEssays 43 (4), 2000159, 2021
52021
Predicting interfacial hot-spot residues that stabilize protein-protein interfaces in oligomeric membrane-toxin pores through hydrogen bonds and salt bridges
R Desikan, PK Maiti, KG Ayappa
Journal of Biomolecular Structure and Dynamics 39 (1), 20-34, 2020
5*2020
Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity
R Desikan, SL Linderman, C Davis, VI Zarnitsyna, H Ahmed, R Antia
Frontiers in Immunology 13, 985478, 2022
42022
CYTOCON DB: A versatile database of human cell and molecule concentrations for accelerating model development
R Desikan, P Jayachandran
CPT: Pharmacometrics & Systems Pharmacology 12 (1), 5, 2023
12023
Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines
R Desikan, SL Linderman, CW Davis, VI Zarnitsyna, HR Ahmed, R Antia
bioRxiv, 2022
12022
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20